PlainPharmaWatch

CMS Open Payments · Tool

BioNTech SE vs Stryker Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

BioNTech SE has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 9,959, versus 67 for the other company. Its single largest recorded recipient represents 99.8% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

BioNTech SE
HHI 9,959 · top recipient 99.8%
Ranked #134 of 1,838 companies by HHI
Stryker Corporation
HHI 67 · top recipient 2.8%
Ranked #1,741 of 1,838 companies by HHI

Payment Overview

Company A

BioNTech SE

Total Payments
$204.8M
% of Industry
1.5%
Transactions
4,756
Avg per Transaction
$43.1K
Recipients
179
Avg per Recipient
$1.1M
Payment Types
5
Top Payment Type
Royalty or License
Total Payments
$141.0M
% of Industry
1.0%
Transactions
169,396
Avg per Transaction
$832.36
Recipients
168,381
Avg per Recipient
$837.37
Payment Types
11
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

BioNTech SE vs Stryker Corporation - total reported payments in CMS Open Payments PY2024

BioNTech SE$204.8MStryker Corporation$141.0M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

BioNTech SE

Royalty or License $180.3M

99.8%

Consulting Fee $172.1K

0.1%

Travel and Lodging $83.0K

0.0%

Compensation for Services Other Than Consulting $19.9K

0.0%

Food and Beverage $4.5K

0.0%

Stryker Corporation

Royalty or License $77.9M

57.8%

Consulting Fee $26.3M

19.6%

Travel and Lodging $7.9M

5.9%

Food and Beverage $7.6M

5.6%

Acquisitions $6.9M

5.1%

Long-Term Medical Supply or Device Loan $4.0M

3.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

BioNTech SE

  1. 1

    Hospital Of The Univ Of Penna

    $180,204,077.24 · 23 txns

  2. 2

    University Of Washington Med Ctr

    $134,500.00 · 2 txns

  3. 3

    JOHN V. HEYMACH

    $25,615.29 · 10 txns

  4. 4

    BHAVANA POTHURI

    $23,357.19 · 11 txns

  5. 5

    PHILIP PHILIP

    $16,454.21 · 8 txns

Stryker Corporation

  1. 1

    JOHN CARBONE

    $3,796,061.86 · 11 txns

  2. 2

    INDIANA UNIVERSITY HEALTH

    $3,531,834.19 · 15 txns

  3. 3

    STEVEN HADDAD

    $2,224,081.35 · 189 txns

  4. 4

    MASSACHUSETTS GENERAL HOSPITAL

    $2,156,082.12 · 8 txns

  5. 5

    THOMAS COON

    $1,953,625.22 · 5 txns

Summary Comparison

Metric BioNTech SE Stryker Corporation
Total Payments $204.8M $141.0M
% of Industry Total 1.5% 1.0%
Transaction Count 4,756 169,396
Avg per Transaction $43.1K $832.36
Recipient Count 179 168,381
Avg per Recipient $1.1M $837.37
Payment Type Count 5 11
Top Payment Type Royalty or License Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.